Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic targetMelanie Weingart, Eric H. Raabe, Jacquelyn J. Roth et al.|Oncotarget|2014Cited by 85
Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-NorleucineSabrina Wang, Jeffrey Rubens, Allison R. Hanaford et al.|Clinical Cancer Research|2019Cited by 34
The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicityJeffrey Rubens, Eric H. Raabe, Sabrina Wang et al.|Neuro-Oncology|2017Cited by 23
Abstract 3519: Disrupting glutamine metabolism depletes glutathione and sensitizes atypical teratoid/rhabdoid tumor to carboplatinSabrina Wang, Jeffrey Rubens, Brad Poore et al.|Cancer Research|2018Cited by 0
Abstract 5267: Unbiased metabolic profiling of atypical teratoid/rhabdoid tumors predicts sensitivity to the glutamine metabolic inhibitor 6-diazo-5-oxo-L-norleucineSabrina Wang, Jeffrey H. Rubens, Jesse Alt et al.|Molecular and Cellular Biology / Genetics|2019Cited by 0